Azel Meets 45% of Eritrea’s Pharmaceutical Demand

Development News
azel Pharmaceutical
Founded in June 2003 to meet the demand for quality pharmaceutical products in the country, Azel Pharmaceutical Sh. Co. now meets 45% of the total Pharmaceutical needs.

By Eritrea Mission to AU,

Azel Pharmaceutical Sh. Co. is jointly owned by the Government of Eritrea and the Jordanian Pharmaceutical Manufacturing Company (JPM). It was founded in 2003 in the city of Keren to meet the demand for quality pharmaceutical products.

The Company has the mission of producing, distributing and selling high quality essential drugs at competitive prices and in widening market coverage.

Azel is currently producing 45% of the pharmaceutical products required in Eritrea thereby making enormous contribution to the improvement of the health and wellbeing of the society.

The products of the company include, among others, antidiabetic, gastrointestinal, cardiovascular, antifungal, anti-inflammatory, and malarial medicines.

>> ALSO READ : Azel Pharmaceutical: Guaranteeing the Efficacy of Medication and Quality

Azel Pharmaceutical
With the improvement of manufacturing efficiency, the goal of ensuring the sustainability of affordable quality medicines supply in the country has been met with flying colors.